Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectivesCHAPMAN, M. John.Atherosclerosis. 2003, Vol 171, Num 1, pp 1-13, issn 0021-9150, 13 p.Article

Beyond the statins : New therapeutic perspectives in cardiovascular disease preventionCHAPMAN, M. John.Cardiovascular drugs and therapy. 2005, Vol 19, Num 2, pp 135-139, issn 0920-3206, 5 p.Article

Pitavastatin: Novel effects on lipid parametersCHAPMAN, M. John.Atherosclerosis. Supplement (Amsterdam). 2011, Vol 12, Num 3, pp 277-284, issn 1567-5688, 8 p.Article

Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolaseTSELEPIS, Alexandros D; CHAPMAN, M. John.Atherosclerosis. Supplement (Amsterdam). 2002, Vol 3, Num 4, pp 57-68, issn 1567-5688, 12 p.Article

Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stressKONTUSH, Anatol; CHANTEPIE, Sandrine; CHAPMAN, M. John et al.Arteriosclerosis, thrombosis, and vascular biology. 2003, Vol 23, Num 10, pp 1881-1888, issn 1079-5642, 8 p.Article

Nouvelle approche thérapeutique de la réduction des taux plasmatiques des lipoprotéines de basse densité: modulation de son affinité de liaison pour le récepteur apo-B E = New therapeutic apprach to the reduction in plasmatic rates of low density lipoproteins: modulating its link affinity for receptor apo-B ECHAPMAN, M. John; FORGEZ, Patricia.1987, 8 p.Report

Statin therapy in acute coronary syndromes: Mechanistic insight into clinical benefitSPOSITO, Andrei C; CHAPMAN, M. John.Arteriosclerosis, thrombosis, and vascular biology. 2002, Vol 22, Num 10, pp 1524-1534, issn 1079-5642Article

Future of High-Density Lipoprotein Infusion Therapies: Potential for Clinical Management of Vascular DiseaseKINGWELL, Bronwyn A; CHAPMAN, M. John.Circulation (New York, N.Y.). 2013, Vol 128, Num 10, pp 1112-1121, issn 0009-7322, 10 p.Article

Oxidized Phospholipids Are Present on Plasminogen, Affect Fibrinolysis, and Increase Following Acute Myocardial InfarctionLEIBUNDGUT, Gregor; ARAI, Kiyohito; ORSONI, Alexina et al.Journal of the American College of Cardiology. 2012, Vol 59, Num 16, pp 1426-1437, issn 0735-1097, 12 p.Article

Despite Antiatherogenic Metabolic Characteristics, SCD1-Deficient Mice Have Increased Inflammation and AtherosclerosisMACDONALD, Marcia L. E; VAN ECK, Miranda; FIEVET, Catherine et al.Arteriosclerosis, thrombosis, and vascular biology. 2009, Vol 29, Num 3, pp 341-347, issn 1079-5642, 7 p.Article

Carotid atherosclerosis is not related to past tuberculosis in hypercholesterolemic patientsGIRAL, Philippe; KAHN, Jean-Francois; ANDRE, Jean-Michel et al.Atherosclerosis. 2007, Vol 190, Num 1, pp 150-155, issn 0021-9150, 6 p.Article

Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activityHANSEL, Boris; GIRAL, Philippe; NOBECOURT, Estelle et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 10, pp 4963-4971, issn 0021-972X, 9 p.Article

Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemiaCASLAKE, Muriel J; STEWART, Grace; PACKARD, Chris J et al.Atherosclerosis. 2003, Vol 171, Num 2, pp 245-253, issn 0021-9150, 9 p.Article

Effect of Two Intensive Statin Regimens on Progression of Coronary DiseaseNICHOLLS, Stephen J; BALLANTYNE, Christie M; NISSEN, Steven E et al.The New England journal of medicine. 2011, Vol 365, Num 22, pp 2078-2087, issn 0028-4793, 10 p.Article

Inhibition of CETP by Torcetrapib Attenuates the Atherogenicity of Postprandial TG-Rich Lipoproteins in Type IIB HyperlipidemiaGUERIN, Maryse; LE GOFF, Wilfried; DUCHENE, Emilie et al.Arteriosclerosis, thrombosis, and vascular biology. 2008, Vol 28, Num 1, pp 148-154, issn 1079-5642, 7 p.Article

Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activityDE SOUZA, Juliana A; VINDIS, Cecile; KONTUSH, Anatol et al.Atherosclerosis. 2008, Vol 197, Num 1, pp 84-94, issn 0021-9150, 11 p.Article

A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activityKONTUSH, Anatol; COTTA DE FARIA, Eliana; CHANTEPIE, Sandrine et al.Atherosclerosis. 2005, Vol 182, Num 2, pp 277-285, issn 0021-9150, 9 p.Article

Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: Relevance of enzymatic and physicochemical propertiesKONTUSH, Anatol; COTTA DE FARIA, Eliana; CHANTEPIE, Sandrine et al.Arteriosclerosis, thrombosis, and vascular biology. 2004, Vol 24, Num 3, pp 526-533, issn 1079-5642, 8 p.Article

Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectivesBEAUDEUX, Jean-Louis; GIRAL, Philippe; BRUCKER, Eric et al.Clinical chemistry and laboratory medicine. 2004, Vol 42, Num 2, pp 121-131, issn 1434-6621, 11 p.Article

Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemiaBEAUDEUX, Jean-Louis; GIRAL, Philippe; BRUCKERT, Eric et al.Atherosclerosis. 2003, Vol 169, Num 1, pp 139-146, issn 0021-9150, 8 p.Article

Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIBTSIMIHODIMOS, Vasilis; KARABINA, Sonia-Athena P; TAMBAKI, Afroditi P et al.Arteriosclerosis, thrombosis, and vascular biology. 2002, Vol 22, Num 2, pp 306-311, issn 1079-5642Article

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementCHAPMAN, M. John; GINSBERG, Henry N; LESNIK, Philippe et al.European heart journal. 2011, Vol 32, Num 11, pp 1345-1361, issn 0195-668X, 17 p.Article

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitorsCHAPMAN, M. John; LE GOFF, Wilfried; GUERIN, Maryse et al.European heart journal. 2010, Vol 31, Num 2, pp 149-164, issn 0195-668X, 16 p.Article

Conventional Dendritic Cells at the Crossroads Between Immunity and Cholesterol Homeostasis in AtherosclerosisGAUTIER, Emmanuel L; HUBY, Thierry; LESNIK, Philippe et al.Circulation (New York, N.Y.). 2009, Vol 119, Num 17, pp 2367-2375, issn 0009-7322, 9 p.Article

Macrophage Apoptosis Exerts Divergent Effects on Atherogenesis as a Function of Lesion StageGAUTIER, Emmanuel L; HUBY, Thierry; WITZTUM, Joseph L et al.Circulation (New York, N.Y.). 2009, Vol 119, Num 13, pp 1795-1804, issn 0009-7322, 10 p.Article